diabetes

April 3, 2013

“Silent” B cells trigger autoimmunity

Immune cells that recognize self antigens (e.g. insulin), but are functionally silent, can trigger autoimmune diseases such as diabetes.

By Leigh MacMillan
February 28, 2013

Discovery Lecture explores brain’s sensitivity to insulin

Diabetes has a big impact on the brain.

By Bill Snyder
February 18, 2013

Pancreas cells full of potential

Adult cells in the pancreas can return to a less mature state – and then become a different cell type, like the beta cells that secrete insulin.

By Jessica Mazerik
February 14, 2013

Harvard’s Kahn set for Discovery Lecture

C. Ronald Kahn, M.D., renowned for his contributions to the field of insulin signaling and its role in type 2 diabetes and obesity, will deliver the next Flexner Discovery Lecture on Thursday, Feb. 21.

By Bill Snyder
November 8, 2012

Alerts ease surgery for patients with diabetes

A monitoring and alert system developed and implemented at Vanderbilt University Medical Center that prompts caregivers to check glucose levels for patients with diabetes while they are undergoing surgery has been found to help improve outcomes such as reduced abnormal glucose values, fewer surgical site infections and reduced hospital readmissions after surgery.

By VUMC News and Communications
November 8, 2012

Symposium to explore diabetes research at VU

“Diabetes at Vanderbilt: From Molecules to People,” a scientific symposium to highlight diabetes research at Vanderbilt, will take place Wednesday, Nov. 14, from 10 a.m. to 2:30 p.m. in the Vanderbilt Student Life Center.

By Leigh MacMillan
November 8, 2012

Commonly prescribed oral diabetes drug offers cardiac benefits

Patients prescribed the diabetes drug metformin have a lower risk for heart attack, stroke and death than patients taking sulfonylurea drugs.
By VUMC News and Communications
October 23, 2012

Vanderbilt researchers find that diabetes drug could be effective in treating addiction

A drug already used for the medical management of diabetes also reduces the rewarding effects of cocaine in animals, which could have far-reaching implications for patients worldwide who suffer from addiction.
By Craig Boerner
August 30, 2012

Diabetes can’t hold back Little League champion

By Christina Echegaray
July 31, 2012

National type I diabetes prevention trial now an option for younger children

A type I diabetes prevention study that is part of the TrialNet program at Vanderbilt is now enrolling children as young as 8 years old.
By Craig Boerner
June 15, 2012

Family members can often sabotage diabetes care: study

Nonsupportive family members contribute to poor adherence to medication regimens and lower glycemic control in adults with diabetes.
By Craig Boerner
June 12, 2012

Mixed results define 2012 Tennessee Men’s Health Report Card

Heart disease is still the leading cause of death for men in Tennessee and cancer deaths continue to move further away from the Centers for Disease Control and Prevention’s Healthy People 2020 goal, according to the 2012 Tennessee Men’s Health Report Card.
By Craig Boerner
April 12, 2012

Targeting post-transplant diabetes

Targeting diabetes that develops after a stem cell transplant may help moderate graft-vs.-host disease, an adverse effect of the procedure, and improve outcomes.
By VUMC News and Communications
1 … 9 10 11 12 13